{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:00:04Z","timestamp":1787169604360,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"\n Background:<\/jats:title>\n Otitis media with effusion (OME) is a middle ear condition characterized by the accumulation of serous fluid. It is common, though not exclusive; among children with its attendant developmental consequence if missed or untreated in early life. OME could be managed surgically, pharmacologically, or physiologically. EarPopper is a medical device developed for physiologic management of OME, Eustachian tube dysfunction, and related problems. We aim to ascertain the suitability\/efficiency of EarPopper\u00ae device for the treatment of OME in our setting.<\/jats:p>\n <\/jats:sec>\n \n Methodology:<\/jats:title>\n This is a prospective interventional study of volunteers diagnosed with OME from four (4) medical centers in Abuja. Pneumatic otoscopy, video-otoscopy, tympanometry, and pure-tone audiometry were done to confirm the diagnosis. Serial EarPopper sessions were performed twice weekly for 2\u201312 weeks, and outcome was assessed using patients\u2019 reports. The reports include the EarPopper scoring system (ESS) and audiometric parameters (before and after therapy).<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Forty-five patients (17 males and 28 females) aged between 3\u201356 years were enrolled. Thirty-five were diagnosed with bilateral OME and 10 unilateral. All patients had Type-B tympanometry tracing with mild-to-moderate conductive hearing losses and ESS of between 2.45% and 84%. Out of the 45 participants, 32 (71.1%) completed the treatment, whereas 13 (28.9%) were lost to follow-up. Duration of EarPopper treatment ranged from 2 to 12 weeks. The outcome revealed improvement in 26\/32 (81.3%) with significant reduction in ESS (1% to 9.8%). Six patients 6\/32 (18.9%) had persistence symptoms. These 18.9% had the propensity to progress to chronic OME.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n This study highly suggests good prospect in using EarPopper for the management of OME among Africans.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aam.aam_17_21","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T10:25:58Z","timestamp":1647599158000},"page":"65-70","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Update on First African Clinical trial on EarPopper for the Treatment of Otitis Media with Effusion [FCT\/UATH\/HREC\/PR\/330]"],"prefix":"10.4103","volume":"21","author":[{"given":"Titus Sunday","family":"Ibekwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoch Auta","family":"Dahilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Folorunso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tochukwu","family":"Uzochukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bosa I.","family":"Egbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oladeji Raheem","family":"Quadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damtong","family":"Fred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iboro","family":"Etukumana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil C.","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibeneche Onyemuchechi","family":"Gbujie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240831","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/1119-3077.86764","article-title":"Classification and management challenges of otitis media in a resource-poor country","volume":"14","author":"Ibekwe","year":"2011","journal-title":"Niger J Clin Pract"},{"key":"R2-12-20240831","first-page":"S1","article-title":"Clinical practice guideline: Otitis media with effusion (Update)","volume":"154","author":"Rosenfeld","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R3-12-20240831","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1258\/smj.2011.011036","article-title":"The prevalence of ear, nose and throat disorders in preschool children with Down's syndrome in Glasgow","volume":"56","author":"Barr","year":"2011","journal-title":"Scott Med J"},{"key":"R4-12-20240831","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14639\/0392-100X-2456","article-title":"Risk factors for otitis media with effusion in children with adenoid hypertrophy","volume":"40","author":"Songu","year":"2020","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"R5-12-20240831","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/1117-1936.175254","article-title":"Adult onset otitis media with effusion in Lagos","volume":"12","author":"Somefun","year":"2005","journal-title":"Niger Postgrad Med J"},{"key":"R6-12-20240831","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1016\/S0165-5876(99)00170-6","article-title":"Assessment of complications of the condition and of the treatment of otitis media with effusion","volume":"49","author":"Schilder","year":"1999","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R7-12-20240831","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/014556130508400911","article-title":"Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part I: Clinical trial","volume":"84","author":"Arick","year":"2005","journal-title":"Ear Nose Throat J"},{"key":"R8-12-20240831","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/014556130508401013","article-title":"Nonsurgical home treatment of middle ear effusion and associated hearing loss in children. Part II: Validation study","volume":"84","author":"Silman","year":"2005","journal-title":"Ear Nose Throat J"},{"key":"R9-12-20240831","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0042-1748539","article-title":"Efficacy of a modified politzer apparatus in management of eustachian tube dysfunction in adults","volume":"10","author":"Silman","year":"1999","journal-title":"J Am Acad Audiol"},{"key":"R10-12-20240831","first-page":"67","article-title":"Improvised hand-held respirator: Life-saving in the management of moderate to severe COVID-1","volume":"33","author":"Ibekwe","year":"2021","journal-title":"Orient J Med"},{"key":"R11-12-20240831","first-page":"52","article-title":"Use of EarPopper\u00ae for the treatment of otitis media with effusion: A first pilot study in Africa","volume":"33","author":"Ibekwe","year":"2021","journal-title":"Orient J Med"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_17_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:38Z","timestamp":1787166518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_17_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_17_21","relation":{},"ISSN":["1596-3519"],"issn-type":[{"value":"1596-3519","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}